Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster presentation 1

860 - BRCA1 germline mutation analysis among eastern Indian women: Identification of three novel mutations and high-frequency occurrence of 5382insC mutation


19 Dec 2015


Poster presentation 1


Jayasri Basak


Annals of Oncology (2015) 26 (suppl_9): 8-15. 10.1093/annonc/mdv518


J. Basak, A. Chakraborty, A. Mukhopadhyay

Author affiliations

  • Molecular Biology, Netaji Subhas Chandra Bose Cancer Research Institute, 700016 - Kolkata/IN


Abstract 860


Breast cancer (BC) has been identified as an increasing risk among the female cancer patients of West Bengal. Mutations in breast cancer susceptibility genes, BRCA1 and BRCA2 account for more than 80% of hereditary breast and ovarian cancers. To explore the contribution of BRCA1mutations in the development of hereditary BC among these women, we carried out mutation analysis of the BRCA1genein 231BCpatients from eastern India.


130 proband with positive family history and 101 without family history were selected from a tertiary cancer hospital, Kolkatafor the detection of BRCA1 mutations. To predict the functional effect of novel mutations in BRCA1 gene, in-silico analysis and m-RNA folding were performed. Surveillance and preventive measures were proposed to the high-risk individuals.


In total, 18 (7.79%) genetic alterations were identified. Interestingly, 5382insC, a BRCA1 mutation which occurs at a very high frequency in Ashkenazi Jews, was found at a frequency of 3.03% (7/231).Among our patients, two novel missense variants (c.5237AàC; c.5210 GàA)and one novel frame shift mutation (c.4495GC > C) were identified, as evidenced from the Human Genome Variation Society (HGVS) or Breast Cancer Information Core (BIC). Other mutations were UTR-17insg (n = 3); UTR -17ins g and UTR-13gàc (n = 2), UTR-13gàc (n = 1), c.75CàA (n = 1) and c.4675 + 1GàA (n = 1). The in-silicoanalysis revealed that both the novel mutations probably alters the structure and reduces the protein stability of BRCA1.


Thus, our study emphasizes the importance of mutation screening in familial BC, and the potential implications of these findings in genetic counseling and preventive therapy.

Clinical trial identification

Not applicable


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings